Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vo Van Giau, Hyon Lee, Seong Soo A An & John Hulme. (2019) Recent advances in the treatment of C. difficile using biotherapeutic agents. Infection and Drug Resistance 12, pages 1597-1615.
Read now
Read now
Maureen Watt, Aurélien Dinh, Alban Le Monnier & Patrick Tilleul. (2017) Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France. Journal of Medical Economics 20:7, pages 678-686.
Read now
Read now
Greg Hussack & Jamshid Tanha. (2016) An update on antibody-based immunotherapies for Clostridium difficile infection. Clinical and Experimental Gastroenterology 9, pages 209-224.
Read now
Read now
Shumin Zhang, Pingping Xing, Guiping Guo, Hong Liu, Donghai Lin, Chuangchuang Dong, Min Li & Dongxiao Feng. (2016) Development of microbeads of chicken yolk antibodies against Clostridium difficile toxin A for colonic-specific delivery. Drug Delivery 23:6, pages 1940-1947.
Read now
Read now
Mai-Chi N Tran, Marina C Claros & Ellie J C Goldstein. (2013) Therapy of Clostridium difficile infection: perspectives on a changing paradigm. Expert Opinion on Pharmacotherapy 14:17, pages 2375-2386.
Read now
Read now
Articles from other publishers (6)
Adelina Mihaescu, Arlyn Maria Augustine, Hassan Tahir Khokhar, Mohammed Zafran, Syed Shah Mohammed Emmad Masood, Georgiana-Emmanuela Gilca-Blanariu, Adrian Covic & Ionut Nistor. (2021) Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review. BioMed Research International 2021, pages 1-10.
Crossref
Crossref
Elena-Stella Theophilou, Prerna Vohra, Maurice P. Gallagher, Ian R. Poxton & Garry W. Blakely. (2019)
Generation of Markerless Deletions in the Nosocomial Pathogen
Clostridium difficile
by Induction of DNA Double-Strand Breaks
. Applied and Environmental Microbiology 85:3.
Crossref
Crossref
Traian Tache, Răzvan Chirică, Marius-Daniel Radu, Gabriela Gegiu & Sorin Rugină. (2019)
Prevalence of infections with
Clostridium difficile
on potential pathology groups
. Ovidius University Annals of Chemistry 30:1, pages 21-24.
Crossref
Crossref
Michael John Aldape, Savannah Nicole Rice, Kevin Patrick Field, Amy Evelyn Bryant & Dennis Leroy Stevens. (2018) Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro. Journal of Medical Microbiology 67:12, pages 1689-1697.
Crossref
Crossref
Hemant Goyal, Abhilash Perisetti, M. Rubayat Rehman & Umesh Singla. (2018) New and emerging therapies in treatment of Clostridium difficile infection. European Journal of Gastroenterology & Hepatology 30:6, pages 589-597.
Crossref
Crossref
Anke van Engen, Montserrat Casamayor, Fidelma Loftus, Martin Coen, Andy Garnham, Maureen Watt & Larry Lacey. (2015) Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland. Journal of Health Economics and Outcomes Research 2:2, pages 192-206.
Crossref
Crossref